Status:
COMPLETED
The Effect of Oxytocin on Placebo Analgesia: an Experimental Study in Healthy Volunteers
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Mechanisms and Modulators of Placebo Analgesia in Healthy Volunteers
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
Placebo responses contribute to medical treatment outcome. The purpose of this study is to determine whether a single intranasal application of oxytocin can increase the placebo response in an experim...
Detailed Description
Placebo responses contribute to medical treatment outcome. The purpose of this study is to determine whether a single intranasal application of oxytocin can increase the placebo response in an experim...
Eligibility Criteria
Inclusion
- healthy volunteers, male and female
- being German-speaking
- Agreeing to participate, verified by completion of informed consent
Exclusion
- acute or chronic pain condition
- use of any concomitant medication except contraceptives
- currently pregnant (verified by urine pregnancy test) or lactating
- major mental disorder
- Inability to comply with the study procedures
- abnormal pain sensitivity as indicated by pain threshold
- alcohol intake within last 24 hours
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01886014
Start Date
January 1 2012
End Date
September 1 2012
Last Update
June 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246